Morgan Stanley lowered the firm’s price target on Walgreens Boots Alliance to $21 from $22 and keeps an Underweight rating on the shares. Ahead of the company’s Q2 report, the firm is tempering its FY24 EPS estimate to $3.24 from $3.35 to reflect a variable consumer backdrop. While “hopeful” about Walgreens’ turnaround prospects, cost cutting, and pruning of assets, the firm awaits detail on the new CEO’s vision and tells investors it is “still likely too early.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Walgreens Boots Alliance Inc. (WBA) Q2 Earnings Cheat Sheet
- Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
- Walgreen Boots call volume above normal and directionally bullish
- Walgreens Boots Alliance price target lowered to $22 from $23 at Leerink
- Unusually active option classes on open March 15th